Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M501473200 on July 1, 2005

J. Biol. Chem., Vol. 280, Issue 35, 31027-31035, September 2, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/35/31027    most recent
M501473200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J.-H.
Right arrow Articles by Freedman, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J.-H.
Right arrow Articles by Freedman, N. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Platelet-derived Growth Factor Receptor-{beta} Phosphorylates and Activates G Protein-coupled Receptor Kinase-2

A MECHANISM FOR FEEDBACK INHIBITION*

Jiao-Hui Wu, Robi Goswami{ddagger}, Luke K. Kim§, William E. Miller, Karsten Peppel, and Neil J. Freedman||

From the Department of Medicine (Cardiology), Duke University Medical Center, Durham, North Carolina 27710

G protein-coupled receptor kinase-2 (GRK2) serine-phosphorylates the platelet-derived growth factor receptor-{beta} (PDGFR{beta}), and thereby diminishes signaling by the receptor. Because activation of GRK2 may involve phosphorylation of its N-terminal tyrosines by c-Src, we tested whether the PDGFR{beta} itself could tyrosine-phosphorylate and activate GRK2. To do so, we used wild type (WT) and Y857F mutant PDGFR{beta}s in HEK cells, which lack endogenous PDGFRs. The Y857F PDGFR{beta} autophosphorylates normally but does not phosphorylate exogenous substrates. Although PDGF-stimulated Y857F and WT PDGFR{beta}s activated c-Src equivalently, the WT PDGFR{beta} tyrosine-phosphorylated GKR2 60-fold more than the Y857F PDGFR{beta} in intact cells. With purified GRK2 and either WT or Y857F PDGFR{beta}s immunoprecipitated from HEK cells, GRK2 tyrosyl phosphorylation was PDGF-dependent and required the WT PDGFR{beta}, even though the WT and Y857F PDGFR{beta}s autophosphorylated equivalently. This PDGFR{beta}-mediated GRK2 tyrosyl phosphorylation enhanced GRK2 activity: GRK2-mediated seryl phosphorylation of the PDGFR{beta} was 9-fold greater for the WT than for the Y857F in response to PDGF, but equivalent when GRK2 was activated by sequential stimulation of {beta}2-adrenergic and PDGF-{beta} receptors. Furthermore, both PDGFR{beta}-mediated GRK2 tyrosyl phosphorylation and GRK2-mediated PDGFR{beta} seryl phosphorylation were reduced ~50% in intact cells by mutation to phenylalanine of three tyrosines in the N-terminal domain of GRK2. We conclude that the activated PDGFR{beta} itself phosphorylates GRK2 tyrosyl residues and thereby activates GRK2, which then serine-phosphorylates and desensitizes the PDGFR{beta}.


Received for publication, February 8, 2005 , and in revised form, June 30, 2005.

* This work was supported, in part, by National Institutes of Health Grants HL63288 and HL77185 (to N. J. F.) and HL64744 (to K. P.) and by an American Heart Association grant-in-aid (to N. J. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by a Glenn/American Federation for Aging Research Student Scholarship.

§ Supported by a Eugene Stead Medical Student Scholarship.

Present address: Dept. of Molecular Genetics, University of Cincinnati, Cincinnati, OH 45267.

|| To whom correspondence should be addressed: Duke University Medical Center, Box 3187, Durham, NC 27710. Tel.: 919-684-6873; Fax: 919-684-6870; E-mail: neil.freedman{at}duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
X. Cai, J.-H. Wu, S. T. Exum, M. Oppermann, R. T. Premont, S. K. Shenoy, and N. J. Freedman
Reciprocal Regulation of the Platelet-Derived Growth Factor Receptor-{beta} and G Protein-Coupled Receptor Kinase 5 by Cross-Phosphorylation: Effects on Catalysis
Mol. Pharmacol., March 1, 2009; 75(3): 626 - 636.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Chen, H. Long, Z. Wu, X. Jiang, and L. Ma
EGF Transregulates Opioid Receptors through EGFR-mediated GRK2 Phosphorylation and Activation
Mol. Biol. Cell, July 1, 2008; 19(7): 2973 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Wu, R. Goswami, X. Cai, S. T. Exum, X. Huang, L. Zhang, L. Brian, R. T. Premont, K. Peppel, and N. J. Freedman
Regulation of the Platelet-derived Growth Factor Receptor-beta by G Protein-coupled Receptor Kinase-5 in Vascular Smooth Muscle Cells Involves the Phosphatase Shp2
J. Biol. Chem., December 8, 2006; 281(49): 37758 - 37772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement